Efficacy of platelet-rich plasma in the treatment of pain syndrome in knee osteoarthritis: a meta-analysis of the studies with a 6-month follow-up

Introduction The scientific literature database contains numerous studies comparing the efficacy of platelet-rich plasma (PRP) and hyaluronic acid (HA) preparations in knee osteoarthritis, but the results are contradictory due to methodological limitations and high heterogeneity of treatment protocols.

Purpose To compare the data from scientific studies on the effectiveness of using PRP and medium molecular weight HA preparations in the treatment of patients with knee osteoarthritis.

Materials and methods A search of randomized controlled trials was conducted in PubMed, Embase, and the Cochrane Library published in the period 2017–2024 using the following keywords: osteoarthritis, knee joint, intra-articular injections, platelet-rich plasma, hyaluronic acid, WOMAC, and meta-analysis. Studies that examined patients diagnosed with knee osteoarthritis of any severity who received intra-articular injections of PRP or HA and assessed pain using the WOMAC were reviewed. After rigorous selection, four studies with identical treatment protocols were included.

Results The meta-analysis included 4 studies involving 333 patients (164 in the PRP group and 169 in the HA group). The mean WOMAC pain score at 6 months after the start of treatment was 4.52 (SD = 1.59) in the PRP group and 4.95 (SD = 2.07) in the HA group. The effect size of Hedges' g was 0.26 (95 % CI: –0.61 to 1.14; p = 0.336). Egger's test did not reveal a statistically significant publication bias (p = 0.06).

Discussion Our study revealed no significant differences between the use of PRP and HA, which contradicts several previous meta-analyses. This may be due to the use of more stringent inclusion criteria in our analysis and the evaluation of HA preparations with only medium molecular weight.

Conclusion This meta-analysis was aimed to compare the effectiveness of using PRP and medium molecular weight HA in the treatment of patients with knee osteoarthritis and did not reveal statistically significant differences between the groups in severity of pain using the WOMAC system six months after the start of treatment, which indicates comparable effectiveness of these therapy methods.

1. Wang MN, Liu L, Zhao LP, et al. Research of inflammatory factors and signaling pathways in knee osteoarthritis. Zhongguo Gu Shang. 2020;33(4):388-392. (In Chin.) doi: 10.12200/j.issn.1003-0034.2020.04.020.

2. Mironov SP, Omelianenko NP, Orletsky AK, et al. Osteoarthritis: current state of the problem (analytical review). NN Priorov Journal of Traumatology and Orthopedics. 2001;8(2):96-99. (In Russ.) doi: 10.17816/vto98472.

3. Conrozier T. How to Treat Osteoarthritis in Obese Patients? Curr Rheumatol Rev. 2020;16(2):99-104. doi: 10.2174/1573397115666190625105759.

4. Andia I, Abate M. Knee osteoarthritis: Hyaluronic acid, platelet-rich plasma or both in association? Expert Opin Biol Ther. 2014;14(5):635-649. doi: 10.1517/14712598.2014.889677.

5. Saito T, Tanaka S. Molecular mechanisms underlying osteoarthritis development: Notch and NF-κB. Arthritis Res Ther. 2017;19(1):94. doi: 10.1186/s13075-017-1296-y.

6. Wang M, Shen J, Jin H, et al. Recent progress in understanding molecular mechanisms of cartilage degeneration during osteoarthritis. Ann N Y Acad Sci. 2011;1240:61-69. doi: 10.1111/j.1749-6632.2011.06258.x.

7. Lisi C, Perotti C, Scudeller L, et al. Treatment of knee osteoarthritis: platelet-derived growth factors vs. hyaluronic acid. A randomized controlled trial. Clin Rehabil. 2018;32(3):330-339. doi: 10.1177/0269215517724193.

8. Papalia R, Zampogna B, Russo F, et al. Comparing hybrid hyaluronic acid with PRP in end career athletes with degenerative cartilage lesions of the knee. J Biol Regul Homeost Agents. 2016;30(4 Suppl 1):17-23.

9. Raeissadat SA, Ghazi Hosseini P, Bahrami MH, et al. The comparison effects of intra-articular injection of Platelet Rich Plasma (PRP), Plasma Rich in Growth Factor (PRGF), Hyaluronic Acid (HA), and ozone in knee osteoarthritis; a one year randomized clinical trial. BMC Musculoskelet Disord. 2021;22(1):134. doi: 10.1186/s12891-021-04017-x.

10. Filardo G, Kon E, Buda R, et al. Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2011;19(4):528-535. doi: 10.1007/s00167-010-1238-6.

11. Spaková T, Rosocha J, Lacko M, et al. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J Phys Med Rehabil. 2012;91(5):411-417. doi: 10.1097/PHM.0b013e3182aab72.

12. Filardo G, Kon E, Di Martino A, et al. Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial. BMC Musculoskelet Disord. 2012;13:229. doi: 10.1186/1471-2474-13-229.

13. Laudy AB, Bakker EW, Rekers M, Moen MH. Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: a systematic review and meta-analysis. Br J Sports Med. 2015;49(10):657-672. doi: 10.1136/bjsports-2014-094036.

14. Dai WL, Zhou AG, Zhang H, Zhang J. Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis: A Meta-analysis of Randomized Controlled Trials. Arthroscopy. 2017;33(3):659-670.e1. doi: 10.1016/j.arthro.2016.09.024.

15. Gaonkar K, Gaonkar N, Gupta K, et al. Role of arthroscopy in osteoarthritis of the knee joint. Int J Clin Trials. 2015;421(3):42-49. doi: 10.5455/2349-3259.ijct20150503.

16. Zaripova L, Tazhibayeva D, Kabdualieva N, et al. Osteoarthritis: A contemporary view of the problem, the possibilities of therapy and prospects for further research. J Clin Med Kaz. 2022;19(6):6-12. doi: 10.23950/jcmk/12629.

17. Eymard F,Ornetti P,Maillet J, et al.Intra-articular injections of platelet-rich plasma in symptomatic knee osteoarthritis: a consensus statement from French-speaking experts. Knee Surg Sports Traumatol Arthrosc. 2021;29(10):3195-3210. doi: 10.1007/s00167-020-06102-5.

18. Gilat R, Haunschild ED, Knapik DM, et al. Hyaluronic acid and platelet-rich plasma for the management of knee osteoarthritis. Int Orthop. 2021;45(2):345-354. doi: 10.1007/s00264-020-04801-9.

19. Raeissadat SA,Ghorbani E,Sanei Taheri M,etal.MRI ChangesAfterPlatelet Rich Plasma Injectionin Knee Osteoarthritis (Randomized Clinical Trial). J Pain Res. 2020;13:65-73. doi: 10.2147/JPR.S204788.

20. Duymus TM, Mutlu S, Dernek B, et al. Choice of intra-articular injection in treatment of knee osteoarthritis: platelet-rich plasma, hyaluronic acid or ozone options. Knee Surg Sports Traumatol Arthrosc. 2017;25(2):485-492. doi: 10.1007/s00167-016-4110-5.

21. Su K, Bai Y, Wang J, et al. Comparison of hyaluronic acid and PRP intra-articular injection with combined intra-articular and intraosseous PRP injections to treat patients with knee osteoarthritis. Clin Rheumatol. 2018;37(5):1341-1350. doi: 10.1007/s10067-018-3985-6.

22. Wang YC, Lee CL, Chen YJ, et al. Comparing the Efficacy of Intra-Articular Single Platelet-Rich Plasma(PRP) versus Novel Crosslinked Hyaluronic Acid for Early-Stage Knee Osteoarthritis: A Prospective, Double-Blind, Randomized Controlled Trial. Medicina (Kaunas). 2022;58(8):1028. doi: 10.3390/medicina58081028.

23. Cole BJ, Karas V, Hussey K, et al. Hyaluronic Acid Versus Platelet-Rich Plasma: A Prospective, Double-Blind Randomized Controlled Trial Comparing Clinical Outcomes and Effects on Intra-articular Biology for the Treatment of Knee Osteoarthritis. Am J Sports Med. 2017;45(2):339-346. doi: 10.1177/0363546516665809.

24. Lu M, Jin Y. Efficacy Evaluation of the Combined Platelet-Rich Plasma and Hyaluronic Acid after Arthroscopic Joint Debridement in Treating Knee Osteoarthritis. Scanning. 2022;2022:6994017. doi: 10.1155/2022/6994017.

25. Louis ML, Magalon J, Jouve E, et al. Growth Factors Levels Determine Efficacy of Platelets Rich Plasma Injection in Knee Osteoarthritis: A Randomized Double Blind Noninferiority Trial Compared With Viscosupplementation. Arthroscopy. 2018;34(5):1530-1540.e2. doi: 10.1016/j.arthro.2017.11.035.

26. Zhao J, Huang H, Liang G, et al. Effects and safety of the combination of platelet-rich plasma (PRP) and hyaluronic acid (HA) in the treatment of knee osteoarthritis: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2020;21(1):224. doi: 10.1186/s12891-020-03262-w.

27. Filardo G, Previtali D, Napoli F, et al. PRP Injections for the Treatment of Knee Osteoarthritis: A Meta-Analysis of Randomized Controlled Trials. Cartilage. 2021;13(1_suppl):364S-375S. doi: 10.1177/1947603520931170.

28. Barakat AS, Ibrahim NM, Elghobashy O, et al. Prevention of post-traumatic osteoarthritis after intra-articular knee fractures using hyaluronic acid: a randomized prospective pilot study. Int Orthop. 2019;43(11):2437-2445. doi: 10.1007/s00264-019-04360-8.

29. de Sire A, Stagno D, Minetto MA, et al. Long-term effects of intra-articular oxygen-ozone therapy versus hyaluronic acid in older people affected by knee osteoarthritis: A randomized single-blind extension study. J Back Musculoskelet Rehabil. 2020;33(3):347-354. doi: 10.3233/BMR-181294.

30. Li M, Huang Z, Wang S, et al. Intra-articular injections of platelet-rich plasma vs. hyaluronic acid in patients with knee osteoarthritis: Preliminary follow-up results at 6-months. Exp Ther Med. 2021;21(6):598. doi: 10.3892/etm.2021.10030.

31. Desai MJ, Safriel Y. MRI for in vivo Analysis of Ablation Zones Formed by Cooled Radiofrequency Neurotomy to Treat Chronic Joint Pain Across Multiple Axial Spine Sites. J Pain Res. 2022;15:423-430. doi: 10.2147/JPR.S342795.

32. Suurmond R, van Rhee H, Hak T. Introduction, comparison, and validation of Meta-Essentials: A free and simple tool for meta-analysis. Res Synth Methods. 2017;8(4):537-553. doi: 10.1002/jrsm.1260.

33. Dwan K, Li T, Altman DG, Elbourne D. CONSORT 2010 statement: extension to randomised crossover trials. BMJ. 2019;366:l4378. doi: 10.1136/bmj.l4378.

34. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. doi: 10.1186/s13643-016-0384-4.

35. PartanRU,PutraKM,Hafizzanovian H,etal.Clinical Outcome of Multiple Platelet-Rich Plasma InjectionandCorrelation with PDGF-BB in the Treatment of Knee Osteoarthritis. J Pers Med. 2024;14(2):183. doi: 10.3390/jpm14020183.

36. Assirelli E, Filardo G, Mariani E, et al. Effect of two different preparations of platelet-rich plasma on synoviocytes. Knee Surg Sports Traumatol Arthrosc. 2015;23(9):2690-2703. doi: 10.1007/s00167-014-3113-3.

37. Lin KY, Yang CC, Hsu CJ, et al. Intra-articular Injection of Platelet-Rich Plasma Is Superior to Hyaluronic Acid or Saline Solution in the Treatment of Mild to Moderate Knee Osteoarthritis: A Randomized, Double-Blind, Triple-Parallel, Placebo-Controlled Clinical Trial. Arthroscopy. 2019;35(1):106-117. doi: 10.1016/j.arthro.2018.06.035.

38. De Marziani L, Sangiorgio A, Bensa A, et al. Intra-articular injections in sport-active patients with degenerative cartilage lesions or osteoarthritis of the knee: a systematic review. J Exp Orthop. 2023;10(1):112. doi: 10.1186/s40634-023-00674-0.

39. Arden NK, Åkermark C, Andersson M, et al. A randomized saline-controlled trial of NASHA hyaluronic acid for knee osteoarthritis. Curr Med Res Opin. 2014;30(2):279-286. doi: 10.1185/03007995.2013.855631.

40. Di Martino A, Di Matteo B, Papio T, et al. Platelet-Rich Plasma Versus Hyaluronic Acid Injections for the Treatment of Knee Osteoarthritis: Results at 5 Years of a Double-Blind, Randomized Controlled Trial. Am J Sports Med. 2019;47(2):347-354. doi: 10.1177/0363546518814532.

41. Cortet B, Lombion S, Naissant B, et al. Non-Inferiority of a Single Injection of Sodium Hyaluronate Plus Sorbitol to Hylan G-F20: A 6-Month Randomized Controlled Trial. Adv Ther. 2021;38(5):2271-2283. doi: 10.1007/s12325-021-01648-3.

42. Conrozier T, Eymard F, Chouk M, Chevalier X. Impact of obesity, structural severity and their combination on the efficacy of viscosupplementation in patients with knee osteoarthritis. BMC Musculoskelet Disord. 2019;20(1):376. doi: 10.1186/s12891-019-2748-0.

43. Fernández-Ferro M, Fernández-Sanromán J, Blanco-Carrión A, et al. Comparison of intra-articular injection of plasma rich in growth factors versus hyaluronic acid following arthroscopy in the treatment of temporomandibular dysfunction: A randomised prospective study. J Craniomaxillofac Surg. 2017;45(4):449-454. doi: 10.1016/j.jcms.2017.01.010.

44. Anitua E, Sánchez M, Orive G, Andía I. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials. 2007;28(31):4551-4560. doi: 10.1016/j.biomaterials.2007.06.037.

45. Simental-Mendía M,Vílchez-Cavazos JF,Peña-MartínezVM,et al.Leukocyte-poor platelet-rich plasma is more effective than the conventional therapy with acetaminophen for the treatment of early knee osteoarthritis. Arch Orthop Trauma Surg. 2016;136(12):1723-1732. doi: 10.1007/s00402-016-2545-2.

46. Riboh JC, Saltzman BM, Yanke AB, et al. Effect of Leukocyte Concentration on the Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis. Am J Sports Med. 2016;44(3):792-800. doi: 10.1177/0363546515580787.

47. Adams ME, Atkinson MH, Lussier AJ, et al. The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage. 1995;3(4):213-225. doi: 10.1016/s1063-4584(05)80013-5.

48. Altman RD, Rosen JE, Bloch DA, et al. A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial). Semin Arthritis Rheum. 2009;39(1):1-9. doi: 10.1016/j.semarthrit.2009.04.001.

49. Sdeek M, Sabry D, El-Sdeek H, Darweash A. Intra-articular injection of Platelet rich plasma versus Hyaluronic acid for moderate knee osteoarthritis. A prospective, double-blind randomized controlled trial on 189 patients with follow-up for three years. Acta Orthop Belg. 2021;87(4):729-734. doi: 10.52628/87.4.18.

50. Saornil JV, Sánchez Milá Z, Campón Chekroun AM, et al. Comparative Study of the Efficacy of Hyaluronic Acid, Dry Needling and Combined Treatment in Patellar Osteoarthritis-Single-Blind Randomized Clinical Trial. Int J Environ Res Public Health. 2022;19(17):10912. doi: 10.3390/ijerph191710912.

51. Bettonville M, Léon M, Margaux J, et al. Safety and efficacy of a single intra-articular injection of a novel enhanced protein solution (JTA-004) compared to hylan G-F 20 in symptomatic knee osteoarthritis: a randomized, double-blind, controlled phase II/III study. BMC Musculoskelet Disord. 2021;22(1):888. doi: 10.1186/s12891-021-04750-3.

52. Conrozier T, Eymard F, Afif N, et al. Safety and efficacy of intra-articular injections of a combination of hyaluronic acid and mannitol (HAnOX-M) in patients with symptomatic knee osteoarthritis: Results of a double-blind, controlled, multicenter, randomized trial. Knee. 2016;23(5):842-848. doi: 10.1016/j.knee.2016.05.015.

53. Askari A, Gholami T, NaghiZadeh MM, et al. Hyaluronic acid compared with corticosteroid injections for the treatment of osteoarthritis of the knee: a randomized control trail. Springerplus. 2016;5:442. doi: 10.1186/s40064-016-2020-0.

54. Paterson KL, Nicholls M, Bennell KL, Bates D. Intra-articular injection of photo-activated platelet-rich plasma in patients with knee osteoarthritis: a double-blind, randomized controlled pilot study. BMC Musculoskelet Disord. 2016;17:67. doi: 10.1186/s12891-016-0920-3.

55. Bahrami MH, Raeissadat SA, Cheraghi M, et al. Efficacy of single high-molecular-weight versus triple low-molecular-weight hyaluronic acid intra-articular injection among knee osteoarthritis patients. BMC Musculoskelet Disord. 2020;21(1):550. doi: 10.1186/s12891-020-03577-8.

56. Campos ALS, E Albuquerque RSP, da Silva EB, et al. Viscosupplementation in patients with severe osteoarthritis of the knee: six month follow-up of a randomized, double-blind clinical trial. Int Orthop. 2017;41(11):2273-2280. doi: 10.1007/s00264-017-3625-9.

57. Farr J, Gomoll AH, Yanke AB, et al. A Randomized Controlled Single-Blind Study Demonstrating Superiority of Amniotic Suspension Allograft Injection Over Hyaluronic Acid and Saline Control for Modification of Knee Osteoarthritis Symptoms. J Knee Surg. 2019;32(11):1143-1154. doi: 10.1055/s-0039-1696672.

58. Gobbi A, Morales M, Avio G, D’Ambrosi R. Double-blinded prospective randomized clinical trial in knee joint osteoarthritis treatment: safety assessment and performance of trehalose hyaluronic acid versus standard infiltrative therapy based on medium-weight sodium hyaluronate. J Cartil Joint Preserv. 2022;2(3):100043. doi: 10.1016/j.jcjp.2022.100043.

59. Goncars V, Jakobsons E, Blums K, et al. The comparison of knee osteoarthritis treatment with single-dose bone marrow-derived mononuclear cells vs. hyaluronic acid injections. Medicina (Kaunas). 2017;53(2):101-108. doi: 10.1016/j.medici.2017.02.002.

60. Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512-525. doi: 10.1093/ije/dyv080.

61. Almalik O, Zhan Z, van den Heuvel ER. Tests for publication bias are unreliable in case of heteroscedasticity. Contemp Clin Trials Commun. 2021;22:100781. doi: 10.1016/j.conctc.2021.100781.

62. Gjerdevik M, Heuch I. Improving the error rates of the Begg and Mazumdar test for publication bias in fixed effects meta-analysis. BMC Med Res Methodol. 2014;14:109. doi: 10.1186/1471-2288-14-109.

63. Shi L, Lin L. The trim-and-fill method for publication bias: practical guidelines and recommendations based on a large database of meta-analyses. Medicine (Baltimore). 2019;98(23):e15987. doi: 10.1097/MD.0000000000015987.

64. Peters JL, Sutton AJ, Jones DR, et ak. Performance of the trim and fill method in the presence of publication bias and between-study heterogeneity. Stat Med. 2007;26(25):4544-4562. doi: 10.1002/sim.2889.

65. Crowther M, Lim W, Crowther MA. Systematic review and meta-analysis methodology. Blood. 2010;116(17):3140-3146. doi: 10.1182/blood-2010-05-280883.

66. Čehovin G, Bosnjak M, Lozar Manfreda K. Meta-Analyses in Survey Methodology: A Systematic Review. Public Opinion Quarterly. 2018;82(2):641-660. doi: 10.1093/poq/nfy042.

67. Miller LE. Towards reaching consensus on hyaluronic acid efficacy in knee osteoarthritis. Clin Rheumatol. 2019;38(10):2881-2883. doi: 10.1007/s10067-019-04597-z.

68. Raeissadat SA, Babaee M, Rayegani SM, et al. An overview of platelet products (PRP, PRGF, PRF, etc.) in the Iranian studies. Future Sci OA. 2017;3(4):FSO231. doi: 10.4155/fsoa-2017-0045.

69. Vannabouathong C, Bhandari M, Bedi A, et al. Nonoperative Treatments for Knee Osteoarthritis: An Evaluation of Treatment Characteristics and the Intra-Articular Placebo Effect: A Systematic Review. JBJS Rev. 2018;6(7):e5. doi: 10.2106/JBJS.RVW.17.00167.

70. Filardo G, Kon E, Pereira Ruiz MT, et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single-versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc. 2012;20(10):2082-2091. doi: 10.1007/s00167-011-1837-x.

71. Yaradilmis YU, Demirkale I, Safa Tagral A, et al. Comparison of two platelet rich plasma formulations with viscosupplementation in treatment of moderate grade gonarthrosis: A prospective randomized controlled study. J Orthop. 2020;20:240-246. doi: 10.1016/j.jor.2020.01.041.

72. Tretyakov AA, Zinovkin DA, Karpenko FN, et al. Pathomorphologic evaluation of intra-articular injections of soluble platelet-rich plasma for treatment of experimental osteoarthritis. Genij Ortopedii. 2024;30(1):90-98. doi:10.18019/1028-4427-2024-30-1-90-98.